📊 EDAP Key Takeaways
Is Edap Tms S.A. (EDAP) a Good Investment?
Unable to conduct fundamental analysis due to unavailable financial data. All critical income statement, balance sheet, cash flow, and profitability metrics are missing, making it impossible to assess financial health, profitability trends, or growth quality.
EDAP TMS shows improving business quality as higher-margin HIFU revenue is growing strongly and lifting gross margin, but the company remains structurally unprofitable. Fundamentals are mixed: 2024 revenue grew to about €64.1 million and 2025 Q3 margin improved further, yet operating losses, negative operating cash flow, and a declining cash balance keep the financial profile constrained until HIFU growth is large enough to absorb fixed costs.
Why Buy Edap Tms S.A. Stock? EDAP Key Strengths
- No strengths identified
- HIFU is scaling well, with nine-month 2025 HIFU revenue up 42% year over year and Q3 2025 HIFU revenue up 49%, indicating strong growth in the strategic core business
- Gross margin is improving as mix shifts toward HIFU, rising from about 40.4% in 2023 to 41.4% in 2024 and 42.5% for the first nine months of 2025
- Balance sheet leverage was modest at year-end 2024, with about €29.8 million of cash versus roughly €4.6 million of total long-term debt, and the new EIB facility provides added liquidity support
EDAP Stock Risks: Edap Tms S.A. Investment Risks
- Complete absence of financial data in SEC filings
- No revenue, earnings, or cash flow information available
- Inability to assess liquidity, solvency, or operational performance
- The company is still loss-making, with net losses of about €19.0 million in 2024 and €17.7 million in the first nine months of 2025
- Cash burn remains material, with 2024 operating cash outflow of about €13.6 million and cash falling to €10.6 million by September 30, 2025 before relying on new financing
- Total company revenue growth is weak because declining non-core ESWL and distribution businesses are offsetting strong HIFU growth, limiting operating leverage
Key Metrics to Watch
- Revenue and gross profit trends
- Operating cash flow and free cash flow generation
- Balance sheet strength and debt levels
- HIFU revenue growth and system placements/procedure volumes relative to declines in non-core businesses
- Operating cash flow and quarterly cash balance as a test of progress toward self-funded operations
Edap Tms S.A. (EDAP) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
EDAP Profit Margin, ROE & Profitability Analysis
EDAP vs Healthcare Sector: How Edap Tms S.A. Compares
How Edap Tms S.A. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Edap Tms S.A. Stock Overvalued? EDAP Valuation Analysis 2026
Based on fundamental analysis, Edap Tms S.A. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Edap Tms S.A. Balance Sheet: EDAP Debt, Cash & Liquidity
EDAP Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Edap Tms S.A.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.55 indicates the company is currently unprofitable.
EDAP Revenue Growth, EPS Growth & YoY Performance
EDAP SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Edap Tms S.A. (CIK: 0001041934)
📋 Recent SEC Filings
❓ Frequently Asked Questions about EDAP
What is the AI rating for EDAP?
Edap Tms S.A. (EDAP) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 39% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are EDAP's key strengths?
Claude: . ChatGPT: HIFU is scaling well, with nine-month 2025 HIFU revenue up 42% year over year and Q3 2025 HIFU revenue up 49%, indicating strong growth in the strategic core business. Gross margin is improving as mix shifts toward HIFU, rising from about 40.4% in 2023 to 41.4% in 2024 and 42.5% for the first nine months of 2025.
What are the risks of investing in EDAP?
Claude: Complete absence of financial data in SEC filings. No revenue, earnings, or cash flow information available. ChatGPT: The company is still loss-making, with net losses of about €19.0 million in 2024 and €17.7 million in the first nine months of 2025. Cash burn remains material, with 2024 operating cash outflow of about €13.6 million and cash falling to €10.6 million by September 30, 2025 before relying on new financing.
What is EDAP's revenue and growth?
Edap Tms S.A. reported revenue of N/A.
Does EDAP pay dividends?
Edap Tms S.A. does not currently pay dividends.
Where can I find EDAP SEC filings?
Official SEC filings for Edap Tms S.A. (CIK: 0001041934) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is EDAP's EPS?
Edap Tms S.A. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is EDAP a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Edap Tms S.A. has a HOLD rating with 39% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is EDAP stock overvalued or undervalued?
Valuation metrics for EDAP: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy EDAP stock in 2026?
Our dual AI analysis gives Edap Tms S.A. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is EDAP's free cash flow?
Edap Tms S.A.'s operating cash flow is N/A, with capital expenditures of N/A.
How does EDAP compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).